Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation

Exclusion Criteria

• •Patients treated percutaneously with any type of stent other than the SupraFlex Cruz® in the 6 months prior to the index procedure in which he or she is included.
• •Use in the same procedure or in a scheduled procedure of other stents different from the one evaluated for the treatment of another vessel(s).
• •Patients treatment for restenosis or stent thrombosis.
• •Patients presentation in cardiogenic shock or after cardiorespiratory arrest.
• •Patients with allergy to any of the components of the stent to be used.
• •Patients with impossibility for follow-up.
• •Patients with life expectancy less than 1 year.